Episode 88: Daring Greatly – Career Change of a Physician to a Life Coach

Christina Arnold Headshot

Episode 88: Daring Greatly – Career Change of a Physician to a Life Coach

Christina Arnold, MD, gastrointestinal pathologist, University of Colorado, is today’s guest of honor discussing her unconventional career change to a full-time professional “life coach.” Dr. Arnold explains what inspired her to make this change, differentiates a life coach from a psychotherapist and how people should know which professional they need to see, reminds us how mental health is still under-resourced and forgotten among healthcare workers, shares her decision process for choosing a life coaching school and how long school took to complete, discloses typical payment and hours associated with the position, and a host of other discussion points.

Related Resources

N/A

Subscribe to Healthcare Unfiltered

Other Episodes You May Enjoy...

Episode 209: Lymphoma: A Year in Review

Leading into the ASH Annual Meeting, Dr. Kami Maddocks, professor in the Division of Hematology at The Ohio State University and medical director of infusion services at The James Comprehensive Cancer Center, provides an in-depth analysis of advancements in non-Hodgkin lymphoma care, with a focus on aggressive B-cell lymphoma. She explores the evolving roles of

Read More

Episode 208: Vivek’s Takes: ESMO 2024 and AACR Debate

Dr. Vivek Subbiah returns for another edition of Vivek’s Takes, sharing his insights on key updates from ESMO Congress 2024, including breakthroughs in neuroendocrine tumors, gastric cancer, and non-small cell lung cancer. He also delves into the highlights of his AACR debate on integrating early cancer detection with AI, arguing for the transformative potential of

Read More

Episode 207: Advances in Bladder Cancer With Andrea Apolo

Chadi welcomes Dr. Andrea Apolo, an internationally recognized leader in bladder cancer research from the National Cancer Institute. Dr. Apolo shares her expertise on recent advancements in urothelial cancer therapy, including key breakthroughs in checkpoint inhibition that have marked a significant turning point in treatment. The conversation delves into optimal sequencing and combination strategies for

Read More